Related Experiment Video
Updated: Aug 4, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Anti-N-methyl-D-aspartate receptor encephalitis: a prospective study focused on cerebrospinal fluid and clinical
Shouyi Wu1, Huiqin Li2, Yajun Lian3
1Department of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou City, Henan Province, People's Republic of China.
Background And Objective:
To analyze the relationship between brain MRI, clinical symptoms, and cerebrospinal fluid (CSF) and to provide a reference for early diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.
Materials And Methods:
A total of 62 patients with anti-NMDAR encephalitis in Zhengzhou, China (2016-2018) were observed and registered prospectively. First, we analyzed the characteristics of clinical symptoms. Second, according to the disease duration, patients were divided into two groups, and then we analyzed the CSF features. In addition, they were divided into two groups according to the brain MRI, and then the CSF features were analyzed. Finally, the characteristics of cerebrospinal fluid in patients with seizure as the initial symptom were analyzed.
Results:
Seizure presents as the initial symptom in 14 patients (22.5%), including 11 males (78.57%). The proportion and concentration of CSF total protein abnormalities in the early stage group were significantly higher than those in the middle and late group (P < 0.05). The total protein concentration in the abnormal brain MRI group was significantly higher than that in the normal MRI group (P < 0.05).
Conclusion:
Anti-NMDAR encephalitis should be suspected, when male patients complain of seizure as an initial symptom and have simultaneously had headaches or fever prior to onset. The sensitivity of anti-NMDAR antibody is higher in CSF than in serum. Total CSF protein is more prone to elevation in the middle and late stages of anti-NMDAR encephalitis. Brain MRI abnormalities with anti-NMDAR encephalitis are related to the total protein concentration of CSF, which may be related to the disease duration.
Insights
Early diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is aided by analyzing brain MRI, clinical symptoms, and cerebrospinal fluid (CSF) protein levels. Male patients with seizures as an initial symptom may indicate NMDAR encephalitis.
Area of Science:
- Neurology
- Immunology
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neurological disorder.
- Early diagnosis is crucial for effective treatment and improved patient outcomes.
Purpose of the Study:
- To investigate the correlations between brain MRI findings, clinical manifestations, and cerebrospinal fluid (CSF) parameters in NMDAR encephalitis.
- To establish a reference for the early diagnosis of NMDAR encephalitis.
Main Methods:
- Prospective observation of 62 NMDAR encephalitis patients (Zhengzhou, China, 2016-2018).
- Analysis of clinical symptoms, CSF features based on disease duration, and CSF features correlated with brain MRI findings.
- Specific analysis of CSF characteristics in patients presenting with seizures as the initial symptom.
Main Results:
- Seizures occurred as the initial symptom in 22.5% of patients, predominantly males (78.57%).
- CSF total protein abnormalities were significantly higher in the early disease stage compared to middle/late stages (P < 0.05).
- CSF total protein concentration was significantly higher in patients with abnormal brain MRI findings versus normal MRI (P < 0.05).
Conclusions:
- Male patients with initial seizures and preceding headaches or fever warrant suspicion for NMDAR encephalitis.
- CSF demonstrates higher sensitivity for anti-NMDAR antibodies than serum.
- Elevated CSF total protein is more common in middle/late stages; MRI abnormalities correlate with CSF protein concentration and potentially disease duration.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology